FDA plans ultra-fast review of three psychedelic drugs following Trump directive
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression
April 24, 2026
US-Mexico border wall construction is desecrating sacred sites, Indigenous leaders say
Palestinian leader's son wins role in Abbas' party, official says
Community college student from Michigan to be 1st woman to represent US at world welding competition
Israel Q1 GDP shrinks 3.3% annualised as Iran war weighs
3 Finnish divers arrive in the Maldives to remap the search for the bodies of 4 Italian divers
Demand for cruises appears undimmed despite hantavirus and other onboard outbreaks